Compliance and safety

Education first

How to read the protocols

• Source material

  Protocols reproduce dosing, reconstitution, and cycling notes as they appear in the documents we cite. They describe how a regimen has been written down — not what you, specifically, should do.

• Risk levels

  Each compound carries a "Low / Moderate / Elevated" risk note. The label is a coarse summary of literature breadth, regulatory posture, and known side-effect profile. Treat it as a prompt for your own due diligence, not a verdict.

• Talk to a clinician

  If you are considering applying any protocol — including supplements, off-label use, or reference-use compounds — that conversation belongs with a licensed clinician who knows your history. Not with this site.

• Verify against primary sources

  References are kept as accurate as we can make them, but the underlying literature moves quickly and regulatory landscapes shift. Cross-check critical details against the cited papers and current FDA guidance.

Where the literature comes from

Study counts and per-compound study lists are pulled from PubMed via the public NCBI E-utilities API. Mechanism summaries, applications, and FAQs are written from peer-reviewed literature and reference material. The library makes no health claims and does not recommend dosing or therapeutic action — it reports what the published work says, and points at the papers.

Regulatory awareness

Several compounds described on this site sit under active FDA review or carry heightened regulatory scrutiny. Where a compound carries elevated risk, the dossier flags it explicitly. Regulatory landscapes shift fast — check current FDA guidance and your local laws before acting on anything written here.

What this site is not

• ✕

  A pharmacy, dispensary, or supplier of any compound

• ✕

  Medical advice, diagnosis, treatment, or a prescription

• ✕

  A substitute for consultation with a licensed clinician

• ✕

  A guarantee that the published literature is exhaustive or current